TipRanks on MSN

AIM ImmunoTech announces publication on effect of Ampligen

AIM ImmunoTech (AIM) announced that the Journal for ImmunoTherapy of Cancer has published a new peer-reviewed article ...
Seeking Alpha

Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC ...

Five poster presentations to include preclinical data describing new T-cell reprogramming technology being incorporated in LYL119, Lyell’s next product candidate “Our presence at SITC includes ...
Seeking Alpha

Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors

MILAN, Italy and NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a clinical-stage immuno-oncology (I/O) company developing a cell-based platform harnessing the power of ...

AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth

New peer-reviewed article appears in the Journal for ImmunoTherapy of CancerOCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ...